Items where Author is "Poustchi, H."

Article

(2022) Opium Use and Cancer Risk: A Comprehensive Systematic Review and Meta-Analysis of Observational Studies. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. ISSN 1368-5031 1742-1241 J9 - INT J CLIN PRACT

(2022) Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran. Int J Health Policy Manag. pp. 210-217. ISSN 2322-5939

(2022) An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country. JOURNAL OF CLINICAL EPIDEMIOLOGY. pp. 1-11. ISSN 0895-4356 1878-5921 J9 - J CLIN EPIDEMIOL

(2021) Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. International Journal of Cancer. pp. 594-605. ISSN 00207136 (ISSN)

(2021) Prevalence, pattern, and correlates of polypharmacy among iranian type II diabetic patients: Results from pars cohort study. ARCHIVES OF IRANIAN MEDICINE. pp. 657-664. ISSN 10292977 (ISSN)

(2021) The Prospective Epidemiological Research Studies in IrAN (PERSIAN) Birth Cohort protocol: rationale, design and methodology. Longitudinal and Life Course Studies. pp. 241-262. ISSN 1757-9597

(2021) SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. pp. 473-481. ISSN 1473-3099 (Print) 1473-3099

(2020) Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran. Int J Health Policy Manag. ISSN 2322-5939

(2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical Infectious Diseases. pp. 2206-2212. ISSN 1058-4838

(2020) The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology. pp. 1590-1594. ISSN 0815-9319

(2019) Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry. Cancer Epidemiology. pp. 50-58. ISSN 18777821 (ISSN)

(2019) Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet. pp. 672-683. ISSN 0140-6736

(2018) Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium. Bmj Open. ISSN 2044-6055

(2018) Liver Transplantation Status in Iran: A Multi-center Report on the Main Transplant Indicators and Survival Rates. Archives of Iranian Medicine. pp. 275-282. ISSN 1029-2977

(2018) Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. AMERICAN JOURNAL OF EPIDEMIOLOGY. pp. 647-655. ISSN 00029262 (ISSN)

(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504

(2016) The Combined Effects of Healthy Lifestyle Behaviors on All-Cause Mortality: The Golestan Cohort Study. Archives of Iranian Medicine. pp. 752-761. ISSN 1029-2977

(2016) Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepatitis Monthly. ISSN 1735-143X

(2015) Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial. European Journal of Preventive Cardiology. pp. 1609-1617. ISSN 2047-4873